Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

aTYR PHARMA (ATYR) Other Non-Current Assets (2019 - 2025)

Historic Other Non-Current Assets for aTYR PHARMA (ATYR) over the last 7 years, with Q3 2025 value amounting to $2.7 million.

  • aTYR PHARMA's Other Non-Current Assets fell 731.37% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year decrease of 731.37%. This contributed to the annual value of $3.0 million for FY2024, which is 1529.85% down from last year.
  • According to the latest figures from Q3 2025, aTYR PHARMA's Other Non-Current Assets is $2.7 million, which was down 731.37% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, aTYR PHARMA's Other Non-Current Assets registered a high of $3.5 million during Q4 2023, and its lowest value of $152000.0 during Q2 2021.
  • Over the past 5 years, aTYR PHARMA's median Other Non-Current Assets value was $2.9 million (recorded in 2025), while the average stood at $2.4 million.
  • As far as peak fluctuations go, aTYR PHARMA's Other Non-Current Assets soared by 131708.86% in 2022, and later plummeted by 2433.11% in 2025.
  • aTYR PHARMA's Other Non-Current Assets (Quarter) stood at $158000.0 in 2021, then skyrocketed by 1903.16% to $3.2 million in 2022, then rose by 10.08% to $3.5 million in 2023, then fell by 15.3% to $3.0 million in 2024, then fell by 8.1% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.9 million for Q2 2025, and $2.4 million during Q1 2025.